Check out Pro
Top Companies
Recent Trades
Cluster Buys
Sectors
Blog
Join the Insiderviz Pro waitlist
Adaptimmune Therapeutics PLC (ADAP)
All trades on this company by insiders. Hover over bubbles for specific trade details. Drag along the graph for custom price change. Green - Buy, Red - Sell, Orange - Congress Member.
Healthcare
Biotechnology
DATE
INSIDER
COMPANY
OWNED SHARES
SHARES TRADED
PRICE
NET TOTAL
SELL
16 Jan 2024
Bertrand William C JR
Chief Operating Officer, Officer
Adaptimmune Therapeutics PLC
(ADAP)
7,785
-75%
23,589
$0.70
$16,423.07
SELL
16 Jan 2024
Rawcliffe Adrian
Chief Executive Officer, Director, Officer
Adaptimmune Therapeutics PLC
(ADAP)
44,848
-46%
39,384
$0.70
$27,594.00
SELL
16 Jan 2024
Norry Elliot
Chief Medical Officer, Officer
Adaptimmune Therapeutics PLC
(ADAP)
7,785
-72%
20,563
$0.69
$14,106.48
SELL
16 Jan 2024
Lunger John
Chief Patient Supply Officer, Officer
Adaptimmune Therapeutics PLC
(ADAP)
7,785
-74%
22,795
$0.70
$15,888.71
SELL
11 Jan 2024
Norry Elliot
Chief Medical Officer, Officer
Adaptimmune Therapeutics PLC
(ADAP)
11,841
-49%
11,808
$0.85
$10,015.46
SELL
11 Jan 2024
Rawcliffe Adrian
Chief Executive Officer, Director, Officer
Adaptimmune Therapeutics PLC
(ADAP)
26,388
-52%
29,202
$0.85
$24,733.59
SELL
11 Jan 2024
Lunger John
Chief Patient Supply Officer, Officer
Adaptimmune Therapeutics PLC
(ADAP)
7,874
-53%
9,229
$0.85
$7,812.73
SELL
11 Jan 2024
Bertrand William C JR
Chief Operating Officer, Officer
Adaptimmune Therapeutics PLC
(ADAP)
7,874
-53%
9,229
$0.85
$7,812.73
SELL
1 Sep 2023
Rawcliffe Adrian
Chief Executive Officer, Director, Officer
Adaptimmune Therapeutics PLC
(ADAP)
3,449
-41%
2,403
$0.78
$1,874.34
SELL
1 Aug 2023
Lunger John
Chief Patient Supply Officer, Officer
Adaptimmune Therapeutics PLC
(ADAP)
4,718
-39%
3,096
$0.91
$2,803.74
SELL
10 Jul 2023
Menzel Garry E
Director
Adaptimmune Therapeutics PLC
(ADAP)
75,056
-38%
47,702
$0.91
$43,446.98
SELL
27 Jun 2023
Rawcliffe Adrian
Chief Executive Officer, Director, Officer
Adaptimmune Therapeutics PLC
(ADAP)
3,519
-39%
2,333
$0.92
$2,146.36
SELL
31 Jan 2023
Piccina Cintia
Chief Commercial Officer, Officer
Adaptimmune Therapeutics PLC
(ADAP)
19,535
-37%
11,890
$1.87
$22,229.55
SELL
17 Jan 2023
Norry Elliot
Chief Medical Officer, Officer
Adaptimmune Therapeutics PLC
(ADAP)
3,491
-38%
2,159
$1.86
$4,011.42
SELL
17 Jan 2023
Rawcliffe Adrian
Chief Executive Officer, Director, Officer
Adaptimmune Therapeutics PLC
(ADAP)
13,351
-42%
10,057
$1.86
$18,685.91
SELL
17 Jan 2023
Lunger John
Chief Patient Supply Officer, Officer
Adaptimmune Therapeutics PLC
(ADAP)
7,264
-37%
4,440
$1.86
$8,249.52
SELL
17 Jan 2023
Bertrand William C JR
Chief Operating Officer, Officer
Adaptimmune Therapeutics PLC
(ADAP)
7,264
-37%
4,440
$1.86
$8,249.52
SELL
11 Jan 2023
Norry Elliot
Chief Medical Officer, Officer
Adaptimmune Therapeutics PLC
(ADAP)
12,191
-48%
11,292
$1.72
$19,420.95
SELL
11 Jan 2023
Rawcliffe Adrian
Chief Executive Officer, Director, Officer
Adaptimmune Therapeutics PLC
(ADAP)
24,882
-56%
31,805
$1.72
$54,791.45
SELL
11 Jan 2023
Lunger John
Chief Patient Supply Officer, Officer
Adaptimmune Therapeutics PLC
(ADAP)
8,121
-52%
8,816
$1.72
$15,196.89
SELL
11 Jan 2023
Bertrand William C JR
Chief Operating Officer, Officer
Adaptimmune Therapeutics PLC
(ADAP)
8,121
-52%
8,816
$1.72
$15,196.89
SELL
4 Jan 2023
Norry Elliot
Chief Medical Officer, Officer
Adaptimmune Therapeutics PLC
(ADAP)
1,361
-39%
876
$1.69
$1,483.94
SELL
4 Jan 2023
Rawcliffe Adrian
Chief Executive Officer, Director, Officer
Adaptimmune Therapeutics PLC
(ADAP)
6,631
-43%
5,073
$1.69
$8,593.66
SELL
4 Jan 2023
Bertrand William C JR
Chief Operating Officer, Officer
Adaptimmune Therapeutics PLC
(ADAP)
5,781
-38%
3,584
$1.69
$6,071.30
SELL
4 Jan 2023
Lunger John
Chief Patient Supply Officer, Officer
Adaptimmune Therapeutics PLC
(ADAP)
1,725
-38%
1,100
$1.69
$1,863.40
SELL
1 Sep 2022
Rawcliffe Adrian
Chief Executive Officer, Director, Officer
Adaptimmune Therapeutics PLC
(ADAP)
3,316
-43%
2,536
$1.97
$4,993.13
SELL
1 Aug 2022
Lunger John
Chief Patient Supply Officer, Officer
Adaptimmune Therapeutics PLC
(ADAP)
4,829
-38%
2,983
$1.77
$5,290.35
SELL
1 Aug 2022
Piccina Cintia
Chief Commercial Officer, Officer
Adaptimmune Therapeutics PLC
(ADAP)
34,824
-37%
21,040
$1.77
$37,314.44
SELL
5 Jul 2022
Lunger John
Chief Patient Supply Officer, Officer
Adaptimmune Therapeutics PLC
(ADAP)
3,104
-38%
1,973
$1.68
$3,310.89
SELL
27 Jun 2022
Rawcliffe Adrian
Chief Executive Officer, Director, Officer
Adaptimmune Therapeutics PLC
(ADAP)
3,290
-43%
2,562
$1.63
$4,176.06
BUY
20 May 2022
Wood Gavin
Chief Financial Officer, Officer
Adaptimmune Therapeutics PLC
(ADAP)
96,000
+68%
39,000
$0.29
$11,325.60
SELL
18 Jan 2022
Bertrand William C JR
Chief Operating Officer, Officer
Adaptimmune Therapeutics PLC
(ADAP)
7,336
-37%
4,368
$3.19
$13,941.78
SELL
18 Jan 2022
Lunger John
Chief Patient Supply Officer, Officer
Adaptimmune Therapeutics PLC
(ADAP)
7,336
-37%
4,368
$3.19
$13,941.78
SELL
18 Jan 2022
Norry Elliot
Chief Medical Officer, Officer
Adaptimmune Therapeutics PLC
(ADAP)
3,529
-37%
2,121
$3.19
$6,769.81
SELL
18 Jan 2022
Rawcliffe Adrian
Chief Executive Officer, Director, Officer
Adaptimmune Therapeutics PLC
(ADAP)
12,312
-47%
11,096
$3.19
$35,416.22
SELL
11 Jan 2022
Bertrand William C JR
Chief Operating Officer, Officer
Adaptimmune Therapeutics PLC
(ADAP)
3,754
-61%
6,018
$3.55
$21,375.90
SELL
11 Jan 2022
Lunger John
Chief Patient Supply Officer, Officer
Adaptimmune Therapeutics PLC
(ADAP)
1,749
-73%
4,846
$3.55
$17,222.21
SELL
11 Jan 2022
Norry Elliot
Chief Medical Officer, Officer
Adaptimmune Therapeutics PLC
(ADAP)
1,383
-76%
4,624
$3.55
$16,435.42
SELL
11 Jan 2022
Rawcliffe Adrian
Chief Executive Officer, Director, Officer
Adaptimmune Therapeutics PLC
(ADAP)
3,356
-83%
17,408
$3.55
$61,876.65
SELL
4 Jan 2022
Bertrand William C JR
Chief Operating Officer, Officer
Adaptimmune Therapeutics PLC
(ADAP)
5,873
-37%
3,490
$4.06
$14,184.06
SELL
4 Jan 2022
Lunger John
Chief Patient Supply Officer, Officer
Adaptimmune Therapeutics PLC
(ADAP)
1,755
-37%
1,070
$4.06
$4,348.69
SELL
4 Jan 2022
Norry Elliot
Chief Medical Officer, Officer
Adaptimmune Therapeutics PLC
(ADAP)
1,388
-37%
849
$4.06
$3,450.51
SELL
4 Jan 2022
Rawcliffe Adrian
Chief Executive Officer, Director, Officer
Adaptimmune Therapeutics PLC
(ADAP)
6,172
-47%
5,532
$4.06
$22,483.15
SELL
1 Sep 2021
Rawcliffe Adrian
Chief Executive Officer, Director, Officer
Adaptimmune Therapeutics PLC
(ADAP])
3,070
-47%
2,782
$5.20
$14,452.49
SELL
2 Aug 2021
Lunger John
Chief Patient Supply Officer, Officer
Adaptimmune Therapeutics PLC
(ADAP)
4,873
-37%
2,939
$3.58
$10,535.73
SELL
2 Jul 2021
Bertrand William C JR
Chief Operating Officer, Officer
Adaptimmune Therapeutics PLC
(ADAP)
7,329
-37%
4,375
$4.26
$18,658.94
SELL
2 Jul 2021
Lunger John
Chief Patient Supply Officer, Officer
Adaptimmune Therapeutics PLC
(ADAP)
3,170
-37%
1,907
$4.26
$8,133.16
SELL
28 Jun 2021
Rawcliffe Adrian
Chief Executive Officer, Director, Officer
Adaptimmune Therapeutics PLC
(ADAP)
3,058
-47%
2,794
$4.37
$12,209.78
BUY
1 Jun 2021
Alleva Lawrence M
Director
Adaptimmune Therapeutics PLC
(ADAP)
12,600
+100%
12,600
$0.79
$9,954.00
SELL
19 Jan 2021
Norry Elliot
Chief Medical Officer, Officer
Adaptimmune Therapeutics PLC
(ADAP)
3,539
-37%
2,111
$5.67
$11,968.31
SELL
19 Jan 2021
Lunger John
Chief Patient Supply Officer, Officer
Adaptimmune Therapeutics PLC
(ADAP)
7,346
-37%
4,358
$5.67
$24,707.68
SELL
19 Jan 2021
Rawcliffe Adrian
Chief Executive Officer, Director, Officer
Adaptimmune Therapeutics PLC
(ADAP)
13,529
-42%
9,879
$5.67
$56,008.99
SELL
12 Jan 2021
Bertrand William C JR
Chief Operating Officer, Officer
Adaptimmune Therapeutics PLC
(ADAP)
3,768
-37%
2,234
$6.15
$13,744.02
SELL
12 Jan 2021
Lunger John
Chief Patient Supply Officer, Officer
Adaptimmune Therapeutics PLC
(ADAP)
1,767
-37%
1,058
$6.15
$6,509.03
SELL
12 Jan 2021
Norry Elliot
Chief Medical Officer, Officer
Adaptimmune Therapeutics PLC
(ADAP)
1,396
-37%
841
$6.15
$5,174.00
SELL
12 Jan 2021
Rawcliffe Adrian
Chief Executive Officer, Director, Officer
Adaptimmune Therapeutics PLC
(ADAP)
3,695
-42%
2,707
$6.15
$16,654.01
SELL
4 Jan 2021
Lunger John
Chief Patient Supply Officer, Officer
Adaptimmune Therapeutics PLC
(ADAP)
1,760
-37%
1,065
$5.33
$5,674.21
SELL
4 Jan 2021
Bertrand William C JR
Chief Operating Officer, Officer
Adaptimmune Therapeutics PLC
(ADAP)
5,864
-37%
3,499
$5.33
$18,642.32
SELL
4 Jan 2021
Norry Elliot
Chief Medical Officer, Officer
Adaptimmune Therapeutics PLC
(ADAP)
1,392
-37%
845
$5.33
$4,502.08
SELL
4 Jan 2021
Rawcliffe Adrian
Chief Executive Officer, Director, Officer
Adaptimmune Therapeutics PLC
(ADAP)
6,737
-42%
4,967
$5.33
$26,463.68
BUY
14 Dec 2020
Wood Gavin
Chief Financial Officer, Officer
Adaptimmune Therapeutics PLC
(ADAP)
57,000
+72%
24,000
$0.69
$16,550.40
BUY
14 Dec 2020
Bertrand William C JR
Chief Operating Officer, Officer
Adaptimmune Therapeutics PLC
(ADAP)
284,808
+266%
207,000
$0.69
$143,823.61
SELL
1 Sep 2020
Rawcliffe Adrian
Chief Executive Officer, Director, Officer
Adaptimmune Therapeutics PLC
(ADAP)
3,076
-47%
2,776
$8.51
$23,637.36
SELL
3 Aug 2020
Lunger John
Chief Patient Supply Officer, Officer
Adaptimmune Therapeutics PLC
(ADAP)
8,066
-37%
4,823
$9.25
$44,612.75
SELL
3 Aug 2020
TAYTON-MARTIN HELEN KATRINA
Chief Business Officer, Officer
Adaptimmune Therapeutics PLC
(ADAP)
0
-100%
200,000
$8.74
$1,748,180.00
SELL
3 Aug 2020
Rawcliffe Adrian
Chief Executive Officer, Director, Officer
Adaptimmune Therapeutics PLC
(ADAP)
3,064
-47%
2,788
$9.25
$25,789.00
BUY
29 Jun 2020
Wood Gavin
Chief Financial Officer, Officer
Adaptimmune Therapeutics PLC
(ADAP)
33,000
+100%
33,000
$1.62
$53,460.00
BUY
9 Jun 2020
Alleva Lawrence M
Director
Adaptimmune Therapeutics PLC
(ADAP)
12,900
+100%
12,900
$1.89
$24,381.00
SELL
29 May 2020
Noble James
Director
Adaptimmune Therapeutics PLC
(ADAP)
0
-100%
500,000
$9.33
$4,666,000.00
BUY
24 Jan 2020
Sonsini Peter W.
10% Owner
Adaptimmune Therapeutics PLC
(ADAP)
19,500,000
+62%
7,500,000
$0.67
$5,000,250.00
BUY
24 Jan 2020
SANDELL SCOTT D
10% Owner
Adaptimmune Therapeutics PLC
(ADAP)
19,500,000
+62%
7,500,000
$0.67
$5,000,250.00
BUY
24 Jan 2020
MOTT DAVID M
Director, 10% Owner
Adaptimmune Therapeutics PLC
(ADAP)
19,500,000
+62%
7,500,000
$0.67
$5,000,250.00
BUY
24 Jan 2020
Florence Anthony A. Jr.
10% Owner
Adaptimmune Therapeutics PLC
(ADAP)
19,500,000
+62%
7,500,000
$0.67
$5,000,250.00
BUY
24 Jan 2020
Behbahani Ali
Director
Adaptimmune Therapeutics PLC
(ADAP)
19,500,000
+62%
7,500,000
$0.67
$5,000,250.00
BUY
24 Jan 2020
BASKETT FOREST
10% Owner
Adaptimmune Therapeutics PLC
(ADAP)
19,500,000
+62%
7,500,000
$0.67
$5,000,250.00
SELL
14 Jan 2020
Norry Elliot
Chief Medical Officer, Officer
Adaptimmune Therapeutics PLC
(ADAP)
1,326
-40%
911
$5.13
$4,677.71
SELL
14 Jan 2020
Bertrand William C JR
Chief Operating Officer, Officer
Adaptimmune Therapeutics PLC
(ADAP)
3,605
-39%
2,397
$5.13
$12,307.88
SELL
14 Jan 2020
Lunger John
Chief Patient Supply Officer, Officer
Adaptimmune Therapeutics PLC
(ADAP)
1,681
-40%
1,144
$5.13
$5,874.10
SELL
14 Jan 2020
Rawcliffe Adrian
Chief Executive Officer, Director, Officer
Adaptimmune Therapeutics PLC
(ADAP)
3,166
-50%
3,236
$5.13
$16,615.89
SELL
13 Jan 2020
TAYTON-MARTIN HELEN KATRINA
Chief Business Officer, Officer
Adaptimmune Therapeutics PLC
(ADAP)
0
-100%
100,000
$4.50
$450,000.00
SELL
13 Jan 2020
Noble James
Director
Adaptimmune Therapeutics PLC
(ADAP)
0
-100%
300,000
$4.67
$1,400,000.00
SELL
6 Jan 2020
Lunger John
Chief Patient Supply Officer, Officer
Adaptimmune Therapeutics PLC
(ADAP)
1,677
-40%
1,148
$1.20
$1,377.60
SELL
6 Jan 2020
Bertrand William C JR
Chief Operating Officer, Officer
Adaptimmune Therapeutics PLC
(ADAP)
5,632
-39%
3,731
$1.20
$4,477.20
SELL
6 Jan 2020
Rawcliffe Adrian
Chief Executive Officer, Director, Officer
Adaptimmune Therapeutics PLC
(ADAP)
5,804
-50%
5,900
$1.20
$7,080.00
SELL
6 Aug 2019
Amado Rafael
President, R&D, Officer
Adaptimmune Therapeutics PLC
(ADAP)
17,237
-39%
11,043
$2.06
$22,748.58
SELL
14 Jan 2019
Binder-Scholl Gwendolyn Knowlton
Chief Technology Officer, Officer
Adaptimmune Therapeutics PLC
(ADAP)
2,487
-37%
1,514
$5.37
$8,129.27
SELL
14 Jan 2019
Bertrand William C JR
Chief Operating Officer, Officer
Adaptimmune Therapeutics PLC
(ADAP)
3,731
-37%
2,271
$5.37
$12,193.91
SELL
14 Jan 2019
Amado Rafael
President, R & D, Officer
Adaptimmune Therapeutics PLC
(ADAP)
4,974
-37%
3,028
$5.37
$16,258.54
SELL
14 Jan 2019
Rawcliffe Adrian
Chief Financial Officer, Officer
Adaptimmune Therapeutics PLC
(ADAP)
3,318
-48%
3,084
$5.37
$16,559.23
BUY
17 Dec 2018
Alleva Lawrence M
Director
Adaptimmune Therapeutics PLC
(ADAP)
47,280
+100%
47,280
$0.84
$39,715.20
SELL
1 Oct 2018
Binder-Scholl Gwendolyn Knowlton
Chief Technology Officer, Officer
Adaptimmune Therapeutics PLC
(ADAP)
0
-100%
25,000
$13.79
$344,750.00
BUY
7 Sep 2018
Viswanathan Ravi
10% Owner
Adaptimmune Therapeutics PLC
(ADAP)
82,978,670
+22%
15,000,000
$1.67
$25,000,500.00
BUY
7 Sep 2018
Sonsini Peter W.
10% Owner
Adaptimmune Therapeutics PLC
(ADAP)
82,978,670
+22%
15,000,000
$1.67
$25,000,500.00
BUY
7 Sep 2018
SANDELL SCOTT D
10% Owner
Adaptimmune Therapeutics PLC
(ADAP)
82,978,670
+22%
15,000,000
$1.67
$25,000,500.00
BUY
7 Sep 2018
MOTT DAVID M
Director, 10% Owner
Adaptimmune Therapeutics PLC
(ADAP)
82,978,670
+22%
15,000,000
$1.67
$25,000,500.00
BUY
7 Sep 2018
KERINS PATRICK J
10% Owner
Adaptimmune Therapeutics PLC
(ADAP)
82,978,670
+3%
3,000,000
$1.67
$5,000,100.00
BUY
7 Sep 2018
Florence Anthony A. Jr.
10% Owner
Adaptimmune Therapeutics PLC
(ADAP)
82,978,670
+22%
15,000,000
$1.67
$25,000,500.00
BUY
7 Sep 2018
Behbahani Ali
Director
Adaptimmune Therapeutics PLC
(ADAP)
12,000,000
+100%
12,000,000
$1.67
$20,000,400.00
BUY
7 Sep 2018
BASKETT FOREST
10% Owner
Adaptimmune Therapeutics PLC
(ADAP)
82,978,670
+22%
15,000,000
$1.67
$25,000,500.00
BUY
7 Sep 2018
BARRIS PETER J
10% Owner
Adaptimmune Therapeutics PLC
(ADAP)
82,978,670
+22%
15,000,000
$1.67
$25,000,500.00
BUY
7 Sep 2018
BARRETT M JAMES
10% Owner
Adaptimmune Therapeutics PLC
(ADAP)
82,978,670
+3%
3,000,000
$1.67
$5,000,100.00
BUY
7 Sep 2018
New Enterprise Associates 14, L.P.
10% Owner
Adaptimmune Therapeutics PLC
(ADAP)
82,978,670
+3%
3,000,000
$1.67
$5,000,100.00
SELL
29 Aug 2018
Binder-Scholl Gwendolyn Knowlton
Chief Technology Officer, Officer
Adaptimmune Therapeutics PLC
(ADAP)
0
-100%
25,000
$10.25
$256,250.00
SELL
4 Jun 2018
Thompson Peter A.
Director
Adaptimmune Therapeutics PLC
(ADAP)
4,901,310
-0%
18,700
$13.56
$253,631.00
SELL
4 Jun 2018
ORBIMED ADVISORS LLC
Director
Adaptimmune Therapeutics PLC
(ADAP)
4,901,310
-0%
18,700
$13.56
$253,631.00
SELL
30 May 2018
Thompson Peter A.
Director
Adaptimmune Therapeutics PLC
(ADAP)
4,920,010
-3%
171,000
$13.51
$2,310,420.00
SELL
30 May 2018
ORBIMED ADVISORS LLC
Director
Adaptimmune Therapeutics PLC
(ADAP)
4,920,010
-3%
171,000
$13.51
$2,310,420.00
SELL
14 May 2018
Thompson Peter A.
Director
Adaptimmune Therapeutics PLC
(ADAP)
5,091,010
-0%
10,300
$13.50
$139,050.00
SELL
14 May 2018
ORBIMED ADVISORS LLC
Director
Adaptimmune Therapeutics PLC
(ADAP)
5,091,010
-0%
10,300
$13.50
$139,050.00
SELL
27 Mar 2018
Thompson Peter A.
Director
Adaptimmune Therapeutics PLC
(ADAP)
5,101,310
-17%
1,048,067
$11.50
$12,053,730.00
SELL
27 Mar 2018
ORBIMED ADVISORS LLC
Director
Adaptimmune Therapeutics PLC
(ADAP)
5,101,310
-17%
1,048,067
$11.50
$12,053,730.00
BUY
26 Mar 2018
Viswanathan Ravi
10% Owner
Adaptimmune Therapeutics PLC
(ADAP)
79,978,670
+8%
6,571,164
$1.92
$12,587,753.00
BUY
26 Mar 2018
Sonsini Peter W.
10% Owner
Adaptimmune Therapeutics PLC
(ADAP)
79,978,670
+8%
6,571,164
$1.92
$12,587,753.00
BUY
26 Mar 2018
SANDELL SCOTT D
10% Owner
Adaptimmune Therapeutics PLC
(ADAP)
79,978,670
+8%
6,571,164
$1.92
$12,587,753.00
BUY
26 Mar 2018
MOTT DAVID M
Director, 10% Owner
Adaptimmune Therapeutics PLC
(ADAP)
79,978,670
+8%
6,571,164
$1.92
$12,587,753.00
BUY
26 Mar 2018
KERINS PATRICK J
10% Owner
Adaptimmune Therapeutics PLC
(ADAP)
79,978,670
+8%
6,571,164
$1.92
$12,587,753.00
BUY
26 Mar 2018
Florence Anthony A. Jr.
10% Owner
Adaptimmune Therapeutics PLC
(ADAP)
79,978,670
+8%
6,571,164
$1.92
$12,587,753.00
BUY
26 Mar 2018
BASKETT FOREST
10% Owner
Adaptimmune Therapeutics PLC
(ADAP)
79,978,670
+8%
6,571,164
$1.92
$12,587,753.00
BUY
26 Mar 2018
BARRIS PETER J
10% Owner
Adaptimmune Therapeutics PLC
(ADAP)
79,978,670
+8%
6,571,164
$1.92
$12,587,753.00
BUY
26 Mar 2018
BARRETT M JAMES
10% Owner
Adaptimmune Therapeutics PLC
(ADAP)
79,978,670
+8%
6,571,164
$1.92
$12,587,753.00
BUY
26 Mar 2018
New Enterprise Associates 14, L.P.
10% Owner
Adaptimmune Therapeutics PLC
(ADAP)
79,978,670
+8%
6,571,164
$1.92
$12,587,753.00
BUY
21 Mar 2018
Viswanathan Ravi
10% Owner
Adaptimmune Therapeutics PLC
(ADAP)
73,407,500
+1%
1,268,508
$1.91
$2,417,847.00
BUY
21 Mar 2018
Sonsini Peter W.
10% Owner
Adaptimmune Therapeutics PLC
(ADAP)
73,407,500
+1%
1,268,508
$1.91
$2,417,847.00
BUY
21 Mar 2018
SANDELL SCOTT D
10% Owner
Adaptimmune Therapeutics PLC
(ADAP)
73,407,500
+1%
1,268,508
$1.91
$2,417,847.00
BUY
21 Mar 2018
MOTT DAVID M
Director, 10% Owner
Adaptimmune Therapeutics PLC
(ADAP)
73,407,500
+1%
1,268,508
$1.91
$2,417,847.00
BUY
21 Mar 2018
KERINS PATRICK J
10% Owner
Adaptimmune Therapeutics PLC
(ADAP)
73,407,500
+1%
1,268,508
$1.91
$2,417,847.00
BUY
21 Mar 2018
Florence Anthony A. Jr.
10% Owner
Adaptimmune Therapeutics PLC
(ADAP)
73,407,500
+1%
1,268,508
$1.91
$2,417,847.00
BUY
21 Mar 2018
BASKETT FOREST
10% Owner
Adaptimmune Therapeutics PLC
(ADAP)
73,407,500
+1%
1,268,508
$1.91
$2,417,847.00
BUY
21 Mar 2018
BARRIS PETER J
10% Owner
Adaptimmune Therapeutics PLC
(ADAP)
73,407,500
+1%
1,268,508
$1.91
$2,417,847.00
BUY
21 Mar 2018
BARRETT M JAMES
10% Owner
Adaptimmune Therapeutics PLC
(ADAP)
73,407,500
+1%
1,268,508
$1.91
$2,417,847.00
BUY
21 Mar 2018
New Enterprise Associates 14, L.P.
10% Owner
Adaptimmune Therapeutics PLC
(ADAP)
73,407,500
+1%
1,268,508
$1.91
$2,417,847.00
SELL
20 Mar 2018
Rawcliffe Adrian
Chief Financial Officer, Officer
Adaptimmune Therapeutics PLC
(ADAP)
0
-100%
600,000
$1.71
$1,026,000.00
BUY
27 Mar 2017
Thompson Peter A.
Director
Adaptimmune Therapeutics PLC
(ADAP)
6,149,377
+24%
1,190,476
$4.20
$4,999,999.00
BUY
27 Mar 2017
ORBIMED ADVISORS LLC
Director
Adaptimmune Therapeutics PLC
(ADAP)
6,149,377
+24%
1,190,476
$4.20
$4,999,999.00
BUY
27 Mar 2017
Viswanathan Ravi
10% Owner
Adaptimmune Therapeutics PLC
(ADAP)
72,139,000
+21%
12,870,000
$0.70
$9,009,000.00
BUY
27 Mar 2017
Sonsini Peter W.
10% Owner
Adaptimmune Therapeutics PLC
(ADAP)
72,139,000
+21%
12,870,000
$0.70
$9,009,000.00
BUY
27 Mar 2017
SANDELL SCOTT D
10% Owner
Adaptimmune Therapeutics PLC
(ADAP)
72,139,000
+21%
12,870,000
$0.70
$9,009,000.00
BUY
27 Mar 2017
MOTT DAVID M
Director, 10% Owner
Adaptimmune Therapeutics PLC
(ADAP)
72,139,000
+21%
12,870,000
$0.70
$9,009,000.00
BUY
27 Mar 2017
KERINS PATRICK J
10% Owner
Adaptimmune Therapeutics PLC
(ADAP)
72,139,000
+21%
12,870,000
$0.70
$9,009,000.00
BUY
27 Mar 2017
Florence Anthony A. Jr.
10% Owner
Adaptimmune Therapeutics PLC
(ADAP)
72,139,000
+21%
12,870,000
$0.70
$9,009,000.00
BUY
27 Mar 2017
BASKETT FOREST
10% Owner
Adaptimmune Therapeutics PLC
(ADAP)
72,139,000
+21%
12,870,000
$0.70
$9,009,000.00
BUY
27 Mar 2017
BARRIS PETER J
10% Owner
Adaptimmune Therapeutics PLC
(ADAP)
72,139,000
+21%
12,870,000
$0.70
$9,009,000.00
BUY
27 Mar 2017
BARRETT M JAMES
10% Owner
Adaptimmune Therapeutics PLC
(ADAP)
72,139,000
+21%
12,870,000
$0.70
$9,009,000.00
BUY
27 Mar 2017
New Enterprise Associates 14, L.P.
10% Owner
Adaptimmune Therapeutics PLC
(ADAP)
72,139,000
+21%
12,870,000
$0.70
$9,009,000.00
BUY
20 May 2016
Thompson Peter A.
Director
Adaptimmune Therapeutics PLC
(ADAP)
29,753,404
+6%
1,712,400
$10.42
$17,849,568.00
BUY
20 May 2016
ORBIMED ADVISORS LLC
Director
Adaptimmune Therapeutics PLC
(ADAP)
29,753,404
+6%
1,712,400
$10.42
$17,849,568.00
BUY
19 May 2016
Sigal Charles Elliott
Director
Adaptimmune Therapeutics PLC
(ADAP)
314,100
+5%
15,000
$1.56
$23,400.00
BUY
16 May 2016
Sigal Charles Elliott
Director
Adaptimmune Therapeutics PLC
(ADAP)
299,100
+17%
45,000
$1.53
$68,700.00
Home